Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
#Structural Heart Devices Market CAGR Outlook And Future Development#_x000D_
The structural heart devices market size has experienced significant growth in recent years. It is projected to expand from $11.37 billion in 2025 to $12.48 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.8%. Historically, this expansion can be linked to factors such as the rising incidence of structural heart conditions, an aging worldwide demographic, the early uptake of valve replacement technologies, the proliferation of cardiac specialty facilities, and advancements in interventional cardiology methods._x000D_
_x000D_
The structural heart devices market is anticipated to show significant expansion in the upcoming years, with its size projected to reach $17.23 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. This expansion throughout the forecast period is driven by an increasing preference for minimally invasive procedures, growing investments in cardiovascular innovation, the widening scope of pediatric cardiac interventions, the increasing adoption of AI-assisted diagnostics, and a rising demand for durable and long-lasting implants. Notable trends during this period are expected to encompass the growing acceptance of transcatheter heart valve procedures, an increased demand for minimally invasive cardiac implants, the enhanced integration of advanced imaging and navigation systems, the expansion of catheter-based delivery technologies, and a heightened focus on patient-specific device design._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Structural Heart Devices Market Industry Drivers: What’s Behind The Revenue Growth?#_x000D_
The increasing incidence of cardiovascular diseases is anticipated to drive the expansion of the structural heart device market in the future. These conditions, commonly known as CVDs, encompass a range of ailments impacting the heart and circulatory system, specifically ailments like coronary artery disease, heart attacks, and strokes. Globally, instances of cardiovascular diseases, such as heart disease and stroke, have consistently risen, attributed to factors including inactive lifestyles, unhealthy eating patterns, growing obesity levels, tobacco use, and an aging demographic. Structural heart devices address cardiovascular diseases by mending or substituting impaired heart valves, rectifying anatomical flaws, and enhancing cardiac performance and patient health results. As an example, the American Heart Association, a US-based non-profit body, reported in January 2024 that the age-adjusted mortality rate from cardiovascular disease climbed to 233.3 per 100,000 in 2024, representing a 4.0% increase from 224.4 per 100,000 in 2023. Consequently, the growing frequency of cardiovascular diseases is stimulating the development of the structural heart device market._x000D_
_x000D_
#Structural Heart Devices Market Segment Performance And Emerging Opportunities#_x000D_
The structural heart devices market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems_x000D_
2) By Procedure: Replacement Procedures, Repair Procedures_x000D_
3) By Indication: Atrial Septal Defect, Patent Foramen Ovale, Ventricular Septal Defect, Aortic Valve Stenosis, Other Indications_x000D_
4) By Age Group: Pediatric, Adults_x000D_
_x000D_
Subsegments:_x000D_
1) By Heart Valve Devices: Transcatheter Heart Valves, Surgical Heart Valves, Annuloplasty Rings _x000D_
2) By Annuloplasty Rings: Mitral Annuloplasty Rings, Aortic Annuloplasty Rings _x000D_
3) By Occluders: Atrial Septal Defect (Asd) Occluders, Patent Foramen Ovale (Pfo) Occluders _x000D_
4) By Delivery Systems: Balloon Delivery Systems, Catheter-Based Delivery Systems_x000D_
_x000D_
#Structural Heart Devices Market Growth Trends: What’s Shaping The Future Outlook?_x000D_
Companies operating in the structural heart devices market are prioritizing the development of innovative solutions, such as next-generation transcatheter heart valves, to enhance durability, mitigate complications, and expand minimally invasive treatment options. These next-generation transcatheter heart valves are minimally invasive replacement valves, engineered with advanced materials and features like anti-calcification tissue and improved sealing, to increase longevity and decrease complications when compared to prior valves. For instance, in September 2025, Edwards Lifesciences Corporation, a US-based medical technology company, introduced a next-generation transcatheter heart valve platform in India. This platform offers a durable, minimally invasive treatment for aortic stenosis in individuals unsuitable for open-heart surgery. The key attributes of this sophisticated valve include calcification-resistant tissue technology to deter calcium accumulation and improve lifespan, a taller outer sealing skirt to lessen paravalvular leaks, and dry tissue storage for simpler hospital handling. Additionally, the platform supports a “lifetime management” strategy, enabling minimally invasive valve-in-valve procedures for subsequent interventions and ensuring sustained treatment effectiveness._x000D_
_x000D_
#Structural Heart Devices Market Competitive Overview And Top Companies#_x000D_
Major companies operating in the structural heart devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., LivaNova PLC, Meril Life Sciences Pvt. Ltd., CryoLife Inc., Braile Biomédica, Direct Flow Medical Inc., JenaValve Technology Inc., Micro Interventional Devices Inc., CardioKinetix Inc., Xeltis AG, Ancora Heart Inc., JOMDD Inc., Valcare Medical, BioStable Science & Engineering Inc., Comed B.V., Transcatheter Technologies GmbH _x000D_
_x000D_
#View The Full Structural Heart Devices Market Report:#_x000D_
_x000D_
#Structural Heart Devices Market Top Region: Where Does Most Revenue Come From?#_x000D_
North America was the largest region in the structural heart devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.